clinivation, Inc. -

Emerging leader in orthopedic trauma and reconstruction products selects the clinivation clearStart Family of Solution Services to address their top priorities in global market clearance operations with the clinivation Global xi Market Clearance Platform.

Natick, MA, March 16, 2009 - clinivation, Inc. announced today that Acumed, LLC. has selected the clinivation clearStart Family of Solution Services.

"Acumed is an emerging leader in orthopedic trauma and reconstruction products for the upper and lower extremities, and we are pleased they have selected the clinivation clearStart Family of Solution Services to address their top priorities in global market clearance operations with the clinivation Global xi Market Clearance Platform," said Richard Morroney, R.A.C., C.Q.A., clinivation's Vice President, Global Market Clearance Solutions.

The clinivation clearStart family of Solution Services enables executives and their teams to immediately address the top priorities of their global market clearance operations by accelerating a priority-focused implementation of the clinivation Global xi Market clearance Platform.

Acumed, LLC. designs innovative orthopedic implants that help surgeons heal broken bones. Based in Hillsboro, Oregon, Acumed's mission is to aid the afflicted through the ingenuity of their minds, the labor of their hands and the compassion of their hearts.

For more information, please visit www.acumed.net.

Clinivation is the leading provider of integrated solutions that enable global market clearance. Guided by our singular vision - "Excellence in Market Clearance" - clinivation accelerates the entire market clearance cycle to advance new worldwide revenue and achieve new milestones of enterprise value.

Used in over 1,000,000 product registrations by more than 100 companies worldwide, clinivation's end-to-end technology and services deliver on our vision by eliminating revenue traps from global market clearance operations, increasing process velocity with on-demand regulatory intelligence, automating clearance-driven business controls, simplifying content unification into market clearance applications, aligning quality systems with global market clearance priorities, streamlining clinical development with clearance-focused trials, and enabling management with key performance indicators for continuous improvement and effective governance.

The world's leading medical device, diagnostics, hospital supply, and dental supply companies select clinivation because of our medtech industry focus and our unique, integrated solutions that seamlessly adapt to existing business processes and enterprise infrastructure- without the need to write custom code.

Our core brands include the clinivation Global^® xi market clearance platform, clinivation WorldView^® on-demand regulatory intelligence, and clinivation Clinical Suite^® and clinivation Registry Suite^® electronic data capture and clinical data management software.

Founded in 1999, the company is headquartered in Natick, Massachusetts, with regional offices in North America and Asia.

Visit clinivation online at www.clinivation.com